Vijay Viswanathan - Genetic Mutations

Author Information

Dr. Vijay Viswanathan is affiliated with the Department of Biochemistry and Molecular Genetics at the Prof. M. Viswanathan Diabetes Research Centre and M.V. Hospital for Diabetes, which is a WHO Collaborating Centre for Research, Education & Training in Diabetes. Additionally, he is associated with the International Diabetes Federation, Centre of Education, and Centre of Excellence in Diabetes Care. The institution is located in Royapuram, Chennai, Tamil Nadu, India.

Research Contributions

Dr. Vijay Viswanathan has made significant contributions to the field of diabetes research and related complications. His recent works focus on the treatment outcomes of people living with type 1 diabetes, the impact of undernutrition on tuberculosis treatment outcomes, and the cost of diabetes treatment in low-resource urban communities in South India. He has also explored the bidirectional link between diabetes mellitus and COVID-19, as well as the role of acute phase proteins in predicting tuberculosis treatment failure. His research is characterized by its focus on public health issues pertinent to diabetes and its complications.

Aliases

V V Viswanathan, V Viswanathan, V. Viswanathan, Vijay Viswanathan

Publication and Citation Metrics

Metric	Value
Number of Papers	272
Citation Count	6639
h-index	43

Publications:

Correction to: Regular hospital visits and treatment outcomes among people living with type 1 diabetes: a 7-year study from South India

DOI: 10.1007/s13410-022-01070-7

Year: 2022

Serum levels of novel anti-inflammatory cytokine Interleukin-38 in diabetes patients infected with latent tuberculosis (DM-LTB-3).

DOI: 10.1016/j.jdiacomp.2022.108133

Year: 2022

Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter Prospective Cohort Analysis

DOI: 10.2139/ssrn.4077891

Year: 2022

Cost of diabetes treatment in private facilities for low resource urban community in South India

DOI: 10.1007/s13410-022-01047-6

Year: 2022

Regular hospital visits and treatment outcomes among people living with type 1 diabetes: a 7-year study from South India

DOI: 10.1007/s13410-022-01053-8

Year: 2022

Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.

DOI: 10.1093/cid/ciac236

Year: 2022

Wilson disease tissue classification and characterization using seven artificial intelligence models embedded with 3D optimization paradigm on a weak training brain magnetic resonance imaging datasets: a supercomputer application

DOI: 10.1007/s11517-021-02322-0

Year: 2021

Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review

DOI: 10.4239/wjd.v12.i3.215

Year: 2021

Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure

DOI: 10.3389/fimmu.2021.731878

Year: 2021

Diabetes Mellitus and Heart Failure: A Consensus Statement

DOI: 10.1007/s13410-021-00956-2

Year: 2021

What are inherited genetic mutations?

What are Immunotherapies?

What are Mutant Crop Varieties?

What Are the Benefits of Pharmacogenomics?

What is the Future of Hemophilia Research?

What is the Molecular Basis of Genetic Diseases?

What Tools Are Used in Phylogenetic Analysis?

How Are Translocations Diagnosed?

What is the Delta F508 Mutation?

How Does Substitution Occur?

Partnered Content Networks

Relevant Topics